D-0153-2017 Class II Terminated
FDA drug recall D-0153-2017 was initiated by Hospira Inc. on Nov 1, 2016 and is designated Class II. Reason for recall: Lack of Assurance of Sterility: Complaints of broken tips on the ampules. The recall status is terminated (terminated Aug 28, 2018). Affected quantity: 797,800 ampules.
Recall details
- Product Type
- Drugs
- Report Date
- Nov 30, 2016
- Initiation Date
- Nov 1, 2016
- Termination Date
- Aug 28, 2018
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 797,800 ampules
Product description
Fentanyl Citrate Injection, USP, 100 mcg Fentanyl/ 2mL, Single Dose, 50 mcg/mL, Rx only, Hospira, Inc., Lake Forest IL 60045, NDC 0409-4093-32
Reason for recall
Lack of Assurance of Sterility: Complaints of broken tips on the ampules.
Distribution pattern
Nationwide
Code information
Lot #5 9277EV, 60028EV, 6008EV, Exp 11/1/17
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0153-2017
- openFDA file date
- Nov 19, 2026
- Loaded by RegDataLab
- Nov 20, 2026
Need the full FDA record for Hospira Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.